Sign In
Buy IBB
$190.15
+4.24 (+2.28%)
At Close: Aug 04, 2026
Trump expresses confidence for coronavirus vaccine ‘by the end of the year’
07:12pm, Monday, 04'th May 2020
Dr. Leana Wen, Emergency Physician and Visiting Professor at George Washington University School of Public Health, joins Yahoo Finance’s Seana Smith to discuss the outlook on a timeline for a corona
Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates
12:00am, Sunday, 03'rd May 2020
April turned out to be a productive month in terms of drug approvals, with the FDA issuing positive verdicts on almost all applications for which decisions were due. The month saw...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
Levels For Market Indices And Key Sectors
09:00pm, Thursday, 30'th Apr 2020
Whether today was a key reversal or just some liquidation and digestion after the recent move up remains to be seen.
Biotech ETFs Gain on New Positive Data for Gilead's Remdesivir
08:50pm, Thursday, 30'th Apr 2020
As the coronavirus continues to spread, the latest positive data on remdesivir is some relief in such challenging times.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1
12:00am, Thursday, 30'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 29)
• Arvinas Inc (NASDAQ...
Sugar - Is It Bottoming, Again?
10:27pm, Wednesday, 29'th Apr 2020
Sugar futures or the sugar continuous contract rallied 4.5% today, leaving a potential bottoming pattern. Again. This is important for 2 reasons.
Healthcare ETFs to Gain on Progress in Coronavirus Vaccine
07:29pm, Wednesday, 29'th Apr 2020
The healthcare space is heated up with players rushing to come up with a vaccine for COVID-19.
Gilead Reports Earnings Tomorrow. Here’s What to Expect.
02:33pm, Wednesday, 29'th Apr 2020
Analysts expect the company to report earnings of $1.46 per share for the first quarter of 2020, and sales of $5 billion, according to FactSet.
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:00am, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 28.)
AstraZeneca plc (NYSE:...
Gold - From Monthly Dojis To Today
11:32pm, Tuesday, 28'th Apr 2020
With the huge earnings week, central bank bond buying, burgeoning money supply, and a market that has rallied off the lows way more than most expected, time to look at the metal.
The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update
11:36am, Tuesday, 28'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 27)
AstraZeneca plc (NYSE: AZN...
Duncker Streett & Co. Inc. Sells 125 Shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)
09:34am, Tuesday, 28'th Apr 2020
Duncker Streett & Co. Inc. cut its holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 5.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned
If Traders Lived Under A Rock
10:24pm, Monday, 27'th Apr 2020
The simplest and most rounded way to look at price.
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Sold by Lincoln National Corp
10:10am, Monday, 27'th Apr 2020
Lincoln National Corp trimmed its position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 3.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exc
